Literature DB >> 15707698

Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures.

B A Guillet1, L J Velly, B Canolle, F M Masmejean, A L Nieoullon, P Pisano.   

Abstract

This study described the involvement of short-term PKA, PKC or PI3K phosphorylation-mediated processes in the regulation of activity and trafficking of the excitatory amino acid transporters EAAC1, GLAST and GLT-1 endogenously expressed in neuron-enriched cultures. Glutamate uptake was dose-dependently decreased by inhibitors of protein kinase A (PKA), [N-[2-(p-bromocinnamylamino)-ethyl]-5-(isoquinolinesulfonamide)] (H89) or phosphatidylinositol 3-kinase (PI3K) (wortmannin), but not altered after protein kinase C (PKC) inhibition (staurosporine) or activation phorbol-12-myristate-13-acetate (PMA). Biotinylation and immunoblotting results (% of controls) showed that EAAC1 membrane expression was significantly decreased by H89 (71.9+/-4.7%) and wortmannin (63.3+/-20.0%) and increased by PMA (137.7+/-15.5%). H89 and PMA induced a significant decrease of the cell surface fraction of GLAST (54.0+/-34.1% and 73.3+/-14.3%, respectively) whereas wortmannin significantly increased this fraction (119.8+/-9.3%). After treatment with H89, the GLT-1 membrane level showed a two-fold increase (179.4+/-19.7%). Conversely, PMA and wortmannin induced a significant decrease of the cell surface expression of GLT-1 (49.0+/-15.4% and 40.7+/-33.7%, respectively). Confocal microscopy revealed a wortmannin-induced clustering of EAAC1 in the intracellular compartment. These data suggest that trafficking of glutamate transporters can be differentially regulated by PKA-, PKC- and PI3K-dependent signaling pathways and could therefore control total glutamate uptake activity. These processes may represent rapid adaptive responses to changes in the cellular environment, which significantly contribute to regulation of EAA transmission and further prevent possible excitotoxic events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707698     DOI: 10.1016/j.neuint.2004.10.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  42 in total

1.  High glutamate decreases S100B secretion by a mechanism dependent on the glutamate transporter.

Authors:  Francine Tramontina; Marina C Leite; Daniela Gonçalves; Ana Carolina Tramontina; Daniela F Souza; Juliana K Frizzo; Patrícia Nardin; Carmem Gottfried; Susana T Wofchuk; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2006-06-23       Impact factor: 3.996

2.  The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies.

Authors:  Eleanor Peacey; Christopher C J Miller; John Dunlop; Marcus Rattray
Journal:  Mol Pharmacol       Date:  2009-02-06       Impact factor: 4.436

3.  Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease.

Authors:  Xueyi Li; Antonio Valencia; Ellen Sapp; Nicholas Masso; Jonathan Alexander; Patrick Reeves; Kimberly B Kegel; Neil Aronin; Marian Difiglia
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

4.  Ubiquitination-mediated internalization and degradation of the astroglial glutamate transporter, GLT-1.

Authors:  Amanda L Sheldon; Marco I González; Elizabeth N Krizman-Genda; Bala T S Susarla; Michael B Robinson
Journal:  Neurochem Int       Date:  2008-08-29       Impact factor: 3.921

5.  Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake.

Authors:  Malav Trivedi; Jayni Shah; Nathaniel Hodgson; Hyang-Min Byun; Richard Deth
Journal:  Mol Pharmacol       Date:  2014-02-25       Impact factor: 4.436

6.  Estrogen attenuates manganese-induced glutamate transporter impairment in rat primary astrocytes.

Authors:  Eunsook Lee; Marta Sidoryk-Wegrzynowicz; Marcelo Farina; Joao B T Rocha; Michael Aschner
Journal:  Neurotox Res       Date:  2012-08-10       Impact factor: 3.911

Review 7.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

8.  Astrocyte GRK2 as a novel regulator of glutamate transport and brain damage.

Authors:  Cora H Nijboer; Cobi J Heijnen; Vincent Degos; Hanneke L D M Willemen; Pierre Gressens; Annemieke Kavelaars
Journal:  Neurobiol Dis       Date:  2013-01-08       Impact factor: 5.996

9.  Phorbol 12-myristate 13-acetate-induced endocytosis of the Na-K-2Cl cotransporter in MDCK cells is associated with a clathrin-dependent pathway.

Authors:  Andreas Mykoniatis; Le Shen; Mary Fedor-Chaiken; Jun Tang; Xu Tang; Roger T Worrell; Eric Delpire; Jerrold R Turner; Karl S Matlin; Patrice Bouyer; Jeffrey B Matthews
Journal:  Am J Physiol Cell Physiol       Date:  2009-10-28       Impact factor: 4.249

10.  Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures.

Authors:  Lúcia Maria Vieira de Almeida; Cristopher Celintano Piñeiro; Marina Concli Leite; Giovana Brolese; Rodrigo Bainy Leal; Carmem Gottfried; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2007-06-27       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.